Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trialMikaël Mazighi, Mathieu Zuber, Robin Lemmens et al.|The Lancet Neurology|2024Cited by 64